ArticlePloS one2022

Health-related quality of life and treatment satisfaction in Chronic Lymphocytic Leukemia (CLL) patients on ibrutinib compared to other CLL treatments in a real-world US cross sectional study.

Kathleen L Deering et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.